DHR vs PG: Which Is the Better Buy?
Side-by-side comparison of Danaher Corporation and The Procter & Gamble Company — fair value, conviction, valuation metrics, and QuantHub research signals.
Updated 2026-09-23.
Danaher Corporation · Healthcare
$221.12
+29.6% upside to fair value
Med Conviction
Grade B
High Quality
VS
The Procter & Gamble Company · Consumer Defensive
$147.04
+14.4% upside to fair value
Med Conviction
Grade B+
High Quality
QuantHub Verdict
DHR has more upside to fair value
(+29.6%).
These are model outputs — not personalized investment advice.
See all research →
Valuation & Fundamentals
| Metric |
DHR |
PG |
| Current Price |
$221.12 |
$147.04 |
| Fair Value Estimate |
$286.52 |
$168.19 |
| Upside to Fair Value |
+29.6%
|
+14.4%
|
| Market Cap |
$155.4B |
$349.5B |
| Forward P/E |
—
|
—
|
| EV / EBITDA |
24.8x
|
17.6x
|
| Price / Sales |
6.2x
|
4.0x
|
| Price / FCF |
28.5x
|
22.4x
|
| Revenue Growth YoY |
+5.5%
|
+1.5%
|
| Gross Margin |
58.5%
|
50.2%
|
| Operating Margin |
20.4%
|
22.7%
|
| Return on Equity |
7.7%
|
29.8%
|
| Dividend Yield |
0.65% |
2.92% |
| FCF Yield |
3.51%
|
4.47%
|
| Analyst Consensus |
Strong Buy
|
Buy
|
Investment Thesis
Danaher is a diversified life-sciences and diagnostics platform spanning three segments: Life Sciences (mass spectrometers, flow cytometry, genomics, bioprocess technologies), Diagnostics (chemistry, immunoassay, microbiology, hematology, molecular and pathology systems), and Environmental & Applied Solutions (water quality and product-identification instrumentation). The business quality is high…
Procter & Gamble is a global consumer-staples leader selling daily-use products across beauty, grooming, health care, fabric and home care, and baby, feminine and family care in about 180 countries. Business quality is high because its brands, consumer insight, R&D, marketing scale and global distribution underpin leading category positions, including over 60% in blades and razors and over 35% in…
Accumulation Zones
| Metric |
DHR |
PG |
| Zone Low |
$214.89 |
$126.14 |
| Zone High |
$243.54 |
$142.96 |
| In Buy Zone? |
Yes
|
No
|